2023 Q1 Form 10-Q Financial Statement

#000149315223004495 Filed on February 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2021 Q4
Revenue $781.2K $1.136M $1.019M
YoY Change 9.24% 11.49% 96.01%
Cost Of Revenue $744.5K $1.061M $1.004M
YoY Change 4.26% 5.67% 93.05%
Gross Profit $36.63K $75.53K $15.37K
YoY Change 3637.76% 391.42%
Gross Profit Margin 4.69% 6.65% 1.51%
Selling, General & Admin $38.17K $91.12K
YoY Change
% of Gross Profit 104.2% 120.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $38.83K $73.81K $36.71K
YoY Change -70.0% 101.05% -69.41%
% of Gross Profit 106.01% 97.71% 238.84%
Operating Expenses $1.983M $2.277M $2.811M
YoY Change -37.97% -19.0% -52.35%
Operating Profit -$1.946M -$2.202M -$2.796M
YoY Change -39.09% -21.25% -52.61%
Interest Expense $5.350K $3.520K -$3.720K
YoY Change -250.28% -194.62% -62.8%
% of Operating Profit
Other Income/Expense, Net -$26.92K $14.95K -$4.670K
YoY Change 9.21% -420.13% -146.7%
Pretax Income -$1.968M -$2.183M -$2.804M
YoY Change -38.96% -22.14% -52.47%
Income Tax
% Of Pretax Income
Net Earnings -$1.968M -$2.183M -$2.804M
YoY Change -38.96% -22.15% -52.44%
Net Earnings / Revenue -251.91% -192.12% -275.12%
Basic Earnings Per Share -$2.80 -$3.23 -$5.45
Diluted Earnings Per Share -$2.80 -$3.23 -$153.8K
COMMON SHARES
Basic Shares Outstanding 691.1K shares 23.67M shares 514.8K shares
Diluted Shares Outstanding 702.9K shares 676.4K shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.699M $6.492M $10.97M
YoY Change -42.77% -40.81% 106.15%
Cash & Equivalents $4.699M $6.492M $10.97M
Short-Term Investments
Other Short-Term Assets $301.4K $376.3K $673.0K
YoY Change -70.23% -44.09% 8.55%
Inventory $1.230M $1.090M $384.2K
Prepaid Expenses
Receivables $421.6K $653.9K $795.3K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.652M $8.612M $12.82M
YoY Change -36.66% -32.82% 99.68%
LONG-TERM ASSETS
Property, Plant & Equipment $402.8K $475.3K $1.182M
YoY Change -73.55% -59.81% -48.36%
Goodwill
YoY Change
Intangibles $125.0K $132.5K
YoY Change
Long-Term Investments $166.1K $167.8K $174.3K
YoY Change -4.04% -3.71% -3.18%
Other Assets $87.22K $91.98K $79.59K
YoY Change -17.21% 15.57% -91.62%
Total Long-Term Assets $1.300M $1.437M $1.436M
YoY Change -51.05% 0.05% -43.67%
TOTAL ASSETS
Total Short-Term Assets $6.652M $8.612M $12.82M
Total Long-Term Assets $1.300M $1.437M $1.436M
Total Assets $7.952M $10.05M $14.26M
YoY Change -39.57% -29.51% 58.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $210.2K $462.7K $681.5K
YoY Change -74.95% -32.12% 3307.65%
Accrued Expenses $756.7K $624.3K $334.6K
YoY Change 43.61% 86.57% -31.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $38.41K $36.73K $60.34K
YoY Change -21.9% -39.13% -39.66%
Total Short-Term Liabilities $1.778M $1.830M $1.499M
YoY Change -13.29% 22.1% 82.77%
LONG-TERM LIABILITIES
Long-Term Debt $6.870K $21.24K $54.56K
YoY Change -84.94% -61.07% -45.44%
Other Long-Term Liabilities $81.13K $77.34K $416.5K
YoY Change -86.32% -81.43% 19.0%
Total Long-Term Liabilities $230.8K $283.9K $471.1K
YoY Change -63.87% -39.73% 4.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.778M $1.830M $1.499M
Total Long-Term Liabilities $230.8K $283.9K $471.1K
Total Liabilities $2.009M $2.114M $1.970M
YoY Change -25.3% 7.31% 53.89%
SHAREHOLDERS EQUITY
Retained Earnings -$68.77M -$66.81M
YoY Change
Common Stock $74.56M $74.54M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.944M $7.935M $12.29M
YoY Change
Total Liabilities & Shareholders Equity $7.952M $10.05M $14.26M
YoY Change -39.57% -29.51% 58.93%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income -$1.968M -$2.183M -$2.804M
YoY Change -38.96% -22.15% -52.44%
Depreciation, Depletion And Amortization $38.83K $73.81K $36.71K
YoY Change -70.0% 101.05% -69.41%
Cash From Operating Activities -$1.737M -$1.913M -$1.580M
YoY Change -32.53% 21.12% -7.07%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $16.51K -$3.010K
YoY Change -100.0% -648.64% -94.98%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$16.51K -$3.010K
YoY Change -100.0% 448.64% -94.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.70K -$8.857K 1.701M
YoY Change -103.5% -100.52% -36.52%
NET CHANGE
Cash From Operating Activities -1.737M -$1.913M -1.580M
Cash From Investing Activities 0.000 -$16.51K -3.010K
Cash From Financing Activities -12.70K -$8.857K 1.701M
Net Change In Cash -1.750M -$1.823M 118.5K
YoY Change -36.34% -1639.11% -87.12%
FREE CASH FLOW
Cash From Operating Activities -$1.737M -$1.913M -$1.580M
Capital Expenditures $0.00 $16.51K -$3.010K
Free Cash Flow -$1.737M -$1.930M -$1.577M
YoY Change -27.98% 22.4% -3.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001527613
CY2022Q4 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2021Q4 us-gaap Restricted Stock Expense
RestrictedStockExpense
usd
CY2021Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2022Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2022Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2022Q4 us-gaap Stock Issued1
StockIssued1
usd
CY2022Q4 NUZE Addition For Right Of Use Of Assets
AdditionForRightOfUseOfAssets
usd
CY2022Q4 NUZE Addition For Lease Liability
AdditionForLeaseLiability
usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
usd
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
usd
CY2022Q4 NUZE Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Forfeited
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q3 NUZE Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding
usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2022Q4 NUZE Share Based Compensation Arrangements By Share Based Payment Award Non Options Granted In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantedInPeriodWeightedAverageExercisePrice
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2022Q4 NUZE Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
shares
CY2022Q4 NUZE Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q4 NUZE Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding
usd
CY2022Q4 NUZE Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Exercisable Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsExercisableAggregateIntrinsicValueNonvested
usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2022Q4 dei Document Type
DocumentType
10-Q
CY2022Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q4 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q4 dei Entity File Number
EntityFileNumber
001-39338
CY2022Q4 dei Entity Registrant Name
EntityRegistrantName
NUZEE, INC.
CY2022Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-3849791
CY2022Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
1350 East Arapaho Road
CY2022Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite #230
CY2022Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Richardson
CY2022Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75081
CY2022Q4 dei City Area Code
CityAreaCode
(760)
CY2022Q4 dei Local Phone Number
LocalPhoneNumber
295-2408
CY2022Q4 dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value
CY2022Q4 dei Trading Symbol
TradingSymbol
NUZE
CY2022Q4 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
691088 shares
CY2022Q4 us-gaap Cash
Cash
6491819 usd
CY2022Q3 us-gaap Cash
Cash
8315053 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
653903 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
345258 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1089901 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
947995 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
376264 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
547773 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
8611887 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
10156079 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
475284 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
525075 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
569521 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
642624 usd
CY2022Q4 us-gaap Investments
Investments
167811 usd
CY2022Q3 us-gaap Investments
Investments
169634 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
132500 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
140000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91979 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
77962 usd
CY2022Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
961811 usd
CY2022Q3 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
1030220 usd
CY2022Q4 us-gaap Assets
Assets
10048982 usd
CY2022Q3 us-gaap Assets
Assets
11711374 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
462655 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
113708 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
8005 usd
CY2022Q3 us-gaap Loans Payable Current
LoansPayableCurrent
7947 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
392714 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
388325 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
28729 usd
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
24518 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
624282 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
706492 usd
CY2022Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
298023 usd
CY2022Q3 us-gaap Deferred Income Current
DeferredIncomeCurrent
319707 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15520 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39241 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1829928 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1599938 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
185351 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
267786 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
18522 usd
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
29622 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
2719 usd
CY2022Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
4745 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
77339 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
66484 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
283931 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
368637 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2113859 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1968575 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
685088 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
685088 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
676229 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
676229 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
7 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
74541365 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
74281418 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66805726 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-64622520 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
199477 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
83894 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7935123 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9742799 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10048982 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11711374 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1136348 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1019253 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
1060816 usd
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
1003882 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
75532 usd
CY2021Q4 us-gaap Gross Profit
GrossProfit
15371 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
2277200 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
2811189 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2201668 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2795818 usd
CY2022Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1823 usd
CY2021Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1157 usd
CY2022Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
50737 usd
CY2021Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
42757 usd
CY2022Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
35790 usd
CY2021Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
47422 usd
CY2022Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5338 usd
CY2021Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2563 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2183206 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2804203 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.23
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.45
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
676422 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
514794 shares
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2183206 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2804203 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
115583 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
32688 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
115583 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
32688 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2067623 usd
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2771515 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9742799 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
197108 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
62839 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
115583 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2183206 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7935123 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
12212447 usd
CY2021Q4 NUZE Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
1721018 usd
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1124187 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
32688 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2804203 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2804203 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
73805 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
12286137 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2183206 usd
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
36711 usd
CY2022Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
73103 usd
CY2021Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
36822 usd
CY2022Q4 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
197108 usd
CY2021Q4 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1124187 usd
CY2022Q4 us-gaap Restricted Stock Expense
RestrictedStockExpense
62839 usd
CY2022Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
65608 usd
CY2022Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1823 usd
CY2021Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1157 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
374253 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
240063 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
141906 usd
CY2021Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-189266 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-171509 usd
CY2021Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-66527 usd
CY2022Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
14017 usd
CY2021Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-231 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
348947 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
81507 usd
CY2022Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-21684 usd
CY2021Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
151397 usd
CY2022Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-78046 usd
CY2021Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-36949 usd
CY2022Q4 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-105931 usd
CY2021Q4 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-188084 usd
CY2022Q4 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
10855 usd
CY2021Q4 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1763 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1913446 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1579731 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16514 usd
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3009 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16514 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3009 usd
CY2022Q4 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1968 usd
CY2021Q4 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
13975 usd
CY2022Q4 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
6889 usd
CY2021Q4 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
5841 usd
CY2021Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1721018 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8857 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1701202 usd
CY2022Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
115583 usd
CY2021Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32688 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1823234 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
151150 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8315053 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10815954 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3732 shares
CY2022Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
114.37
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
109632 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
151.19
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6491819 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10967104 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
1474 usd
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
2808 usd
CY2021Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
192397 usd
CY2021Q4 us-gaap Stock Issued1
StockIssued1
257234 usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M12D
CY2022Q4 us-gaap Cash
Cash
6491819 usd
CY2022Q4 NUZE Working Capital
WorkingCapital
6781959 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
66761 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
171.55
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y4M24D
CY2022Q4 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84D_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zEJ28vEh7TQb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zTk0cssDSFh8">Reclassification</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. We reclassified lease expenses associated with subleased property from operating expenses to other expenses totaling $<span id="xdx_90C_ecustom--RecalssificationFromOperatingExpensesToOtherExpenses_pp0p0_c20221001__20221231_zwBArdZdTqMl" title="Recalssification from operating expenses to other expenses">41,604</span> for the three months ended December 31, 2021. This reclassification had no effect on the previously reported net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 NUZE Recalssification From Operating Expenses To Other Expenses
RecalssificationFromOperatingExpensesToOtherExpenses
41604 usd
CY2022Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
l-for-35 reverse stock split
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
262030 shares
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
250471 shares
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
642624 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
73103 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
569521 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
656111 usd
CY2022Q4 NUZE Operating Lease Lease Liability Amortization Expense
OperatingLeaseLeaseLiabilityAmortizationExpense
78046 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
578065 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
392714 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
185351 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
578065 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
379603 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
217301 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
33908 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
630812 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
52747 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
578065 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
392714 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
185351 usd
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M
CY2022Q4 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.1275 pure
CY2022Q4 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1474 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
33113 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
19315 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
52428 usd
CY2022Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
5177 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
47251 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
28729 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
18522 usd
CY2022Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
114131 usd
CY2022Q4 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1474 usd
CY2022Q4 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6889 usd
CY2022Q4 us-gaap Sublease Income
SubleaseIncome
50738 usd
CY2022Q4 NUZE Sub Lease Liability Payments Due Next Twelve Months
SubLeaseLiabilityPaymentsDueNextTwelveMonths
127926 usd
CY2022Q4 NUZE Sublease Liability Payments Due Year Two
SubleaseLiabilityPaymentsDueYearTwo
64918 usd
CY2022Q4 NUZE Minimum Lease Payments To Be Received Sublease
MinimumLeasePaymentsToBeReceivedSublease
192844 usd
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
115583 usd
CY2021Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
32688 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
376264 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
547773 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
376264 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
547773 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1089901 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
947995 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1086761 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
887632 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3140 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
60363 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1089901 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
947995 usd
CY2022Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1823 usd
CY2021Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1157 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1136348 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1019253 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
475284 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
525075 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
149.88
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M24D
CY2022Q4 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
876176 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
531412 usd
CY2022Q3 us-gaap Goodwill
Goodwill
0 usd
CY2022Q4 NUZE Non Cash Impairment Charges For The Dripkit Tradename
NonCashImpairmentChargesForTheDripkitTradename
80555 usd
CY2022Q4 NUZE Non Cash Impairment Charges For Acquried Customer
NonCashImpairmentChargesForAcquriedCustomer
63167 usd
CY2021Q4 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1039258 usd
CY2021Q4 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
2840383 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7500 usd
CY2021Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1721018 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3732 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
286 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
113650 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1207 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
286 shares
CY2022Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
109.55
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
50009 shares
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
154.24
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
3732 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
114.90
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
3406 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
368.19
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
42871 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
140.67
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
152398 shares
CY2022Q3 NUZE Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1
158.24
CY2022 NUZE Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm
P3Y8M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
152398 shares
CY2022Q4 NUZE Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1
158.24
CY2022Q4 NUZE Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term Ending Balance
SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTermEndingBalance
P3Y4M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther
152398 shares
CY2022Q4 NUZE Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercisable In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisableInPeriodWeightedAverageExercisePrice
158.24
CY2022Q4 NUZE Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term Exercisable
SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTermExercisable
P3Y4M24D

Files In Submission

Name View Source Status
0001493152-23-004495-index-headers.html Edgar Link pending
0001493152-23-004495-index.html Edgar Link pending
0001493152-23-004495.txt Edgar Link pending
0001493152-23-004495-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
nuze-20221231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nuze-20221231_cal.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nuze-20221231_def.xml Edgar Link unprocessable
nuze-20221231_lab.xml Edgar Link unprocessable
nuze-20221231_pre.xml Edgar Link unprocessable